Yes but not interested in selling. We're days away from getting this into humans and given the speed to which this drug works, should have some feedback shortly. Been in longer than qbiotics has existed so a little more waiting won't harm me. The AGM has traditionally been late in the year so one would think it would be a hot topic.
Also the vet drug is nearing market. With the right backing the market share should be significant. The feedback from vets using the drug is extremely positive and would be a preferred treatment for a wide range of cases. This should provide a strong underpinning of the share price and upside on the current share price given the potential market.
